Abstract:Hepatocyte-like cells (HLCs) derived from human induced pluripotent stem cells (hiPSCs), with their potential capacity to phenotypically model the influence of genetic variation, could be a useful in vitro hepaticmodel to aidmechanistic understanding of drug-induced liver injury in humans. However, the generation of HLCs with a functionally similar phenotype to the gold standard in vitro model of human primary hepatocytes remain elusive. Furthermore there is a significant variation reported for the differentiation propensities of various hiPSC lines towards the hepatic lineage, although the precise reasons are unclear. Recent reports have highlighted the potential importance of the parental cell used for cellular reprogramming, as hiPSCs may retain an epigenetic memory of their original cell type, with a propensity to differentiate back to its lineage of origin. Therefore, we hypothesize that HLCs generated from hepatocyte-derived hiPSCs may exhibit an improved functional phenotype compared to non-hepatocyte-derived hiPSCs. To control for genotypic differences, variations in the reprogramming techniques, and differences in the hepatic differentiation protocols, we derived hiPSC lines from primary hepatocytes and dermal fibroblasts from the same donors using a non-integrative reprogrammingmethod, and generated HLCs using the same differentiation protocol. The hepatocyte-derived hiPSC (H-hiPSC) lines and dermal fibroblast-derived hiPSC (F-hiPSC) lines successfully generated from the same donors were positive for the pluripotency markers OCT4, SOX2, NANOG, TRA-1-60 and SSEA4, and could spontaneously differentiate into cells of all three germ layers. HLCs were differentiated from all the hiPSC lines and were shown to be positive for the endodermal lineage-specific markers of SOX17, HNF4A and ALB. The HLCs were generated using hiPSCs at low passage numbers (<10) to avoid any loss of epigenetic memory which could arise as a result of continued passage in culture. Separate cultures of HLCs generated from the H-hiPSC and F-hiPSC lines were compared against the donors' primary hepatocytes using real-time PCR for expression of liver-related genes, immunoblotting and assays of key hepatic metabolic function. Our resource of having H-hiPSC and F-hiPSC lines to generate HLCs, with the availability of primary hepatocytes from the same donor as the most appropriate comparator, allows for a definitive assessment of the role of epigenetic memory of the cell origin used for cellular reprogramming, in determining the propensity for hepatic differentiation.

Bioinformatics Analysis to Screen Key Genes Implicated in the Differentiation of Induced Pluripotent Stem Cells to Hepatocytes

Analysis of differentially expressed genes among human hair follicle–derived iPSCs, induced hepatocyte-like cells, and primary hepatocytes

Donor-Dependent and Other Nondefined Factors Have Greater Influence on the Hepatic Phenotype Than the Starting Cell Type in Induced Pluripotent Stem Cell Derived Hepatocyte-Like Cells

Microarray Analysis of Differentiation of Mouse Embryonic Stem Cells into Hepatocyte-like Cells*

Identification of Genes During the Reprogramming of Fibroblast using Bioinformatics Analysis

Efficient Generation of Functional Hepatocyte-Like Cells from Mouse Liver Progenitor Cells Via Indirect Co-Culture with Immortalized Human Hepatic Stellate Cells.

Hepatocyte-like cells derived from human induced pluripotent stem cells using small molecules: implications of a transcriptomic study

Key Genes and Integrated Modules in Hematopoietic Differentiation of Human Embryonic Stem Cells: a Comprehensive Bioinformatic Analysis

Identifying in Vitro Cultured Human Hepatocytes Markers with Machine Learning Methods Based on Single-Cell RNA-Seq Data

Roles and Mechanisms of Action of HNF‑4α in the Hepatic Differentiation of WB‑F344 Cells.

Screening and Identification of Key Biomarkers in Hepatocellular Carcinoma: Evidence from Bioinformatic Analysis

Transcriptome Analysis of Induced Pluripotent Stem Cell (iPSC)-derived Pancreatic β-like Cell Differentiation

643 Mutations in Cel and Hras1 Are Associated with Obesity-Associated Hepatocellular Carcinoma

Genetic and Chemical Screenings Identify HDAC3 As a Key Regulator in Hepatic Differentiation of Human Pluripotent Stem Cells.

Generation of functional hepatocytes from mouse induced pluripotent stem cells.

Identification of Key Candidate Genes and Pathways in Hepatocellular Carcinoma by Integrated Bioinformatical Analysis.

Induction of Hepatocytes-Derived Insulin-Producing Cells Using Small Molecules and Identification of Microrna Profiles During This Procedure.

In Vivo Liver Regeneration Potential of Human Induced Pluripotent Stem Cells from Diverse Origins

A liver‐specific gene expression panel predicts the differentiation status of in vitro hepatocyte models

Hepatic differentiation of mouse iPS cells and analysis of liver engraftment potential of multistage iPS progeny

Bioinformatics analysis of key genes and pathways for hepatocellular carcinoma transformed from cirrhosis